Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends

Report Code: PHM276A

Publish Date: Sep 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global acute myeloid leukemia (AML) treatments market should reach $6.1 billion by 2028 from $3.8 billion in 2023 at a compound annual growth rate (CAGR) of 10.0% for the forecast period of 2023 to 2028.

Report Includes

  • 42 data tables and 57 additional tables
  • An overview of the global market for acute myeloid leukemia (AML) treatment
  • Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of AML market based on treatment type, route of administration type, end-users, distribution channel, region
  • Coverage of various risk factors associated with AML, such as exposure to radiation or chemicals, genetic disorders, and weakened immune system
  • Description of major treatment options for AML such as, chemotherapy, targeted therapy, and stem cell transplantation
  • Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
  • Detailed company profiles of major players in the market of the industry, including AbbVie, Daiichi Sankyo, GlaxoSmithKline PLC, Pfizer Inc. and Servier

Report Scope

This report aims to comprehensively study the market size of AML and treatments for a global market. Current and historical market revenues can be estimated based on treatment type, route of administration, end use, distribution channel and region.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $3.5 billion
Market size forecast $6.1 billion
Growth rate CAGR of 10.0%
Units considered $ Millions
Segments covered Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, Japan, China, India, Rest of Asia-Pacific, and Middle East and Africa.
Key Market Drivers
  • Growing Elderly Population
  • Increasing Incidence and Prevalence
  • Advancements in Molecular Diagnostics
  • Minimal Residual Disease (MRD) Monitoring
  • Gene Expression Profiling
  • Fusion Gene Detection
  • Liquid Biopsies
  • R&D
  • Regulatory Environment
  • Personalized Medicine
  • Collaborative Efforts
  • Patient Advocacy and Awareness
Companies studied
ABBVIE INC.AMGEN INC.
ASTELLAS PHARMA INC.BAYER AG
BIOGENBRISTOL-MYERS SQUIBB CO.
DAIICHI SANKYO CO. LTD.GILEAD SCIENCES INC.
GSK PLC.MERCK & CO. INC.
NOVARTIS AGPFIZER INC.
SANOFILES LABORATOIRES SERVIER
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global acute myeloid leukemia market is projected to grow from $3.5 billion in 2022 to $6.1 billion in 2028, at a compound annual growth rate (CAGR) of 10.0% during the forecast period.
Growth in this market is fueled by a worldwide increase in aging populations and an increased prevalence of AML. Technological innovation is an additional important catalyst driving the adaptation and increase in the use these drugs are the major factors driving the market growth.
The global acute myeloid leukemia market is segmented based on the product type such targeted therapy, anthracycline drugs, other chemotherapies and by geographic region.
Targeted therapy segment will dominate the market by the end of 2028.
North America (49.3%) holds the highest share in the market.
Key companies in the market include Bristol Myers Squibb, Sanofi-Aventis, Pfizer, Novartis and Amgen.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends122Free
Chapter- 1: Introduction4Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview and Definitions8Free
Chapter- 4: Market Dynamics 7Free
Chapter- 5: Impact of COVID-192Free
Chapter- 6: Market Breakdown by Region8Free
Chapter- 7: Market Breakdown by Treatment Type4Free
Chapter- 8: Market Breakdown by Route of Administration6Free
Chapter- 9: Market Breakdown by Product7Free
Chapter- 10: ESG Development7Free
Chapter- 11: Emerging Trends and Technologies1Free
Chapter- 12: Competitive Landscape6Free
Chapter- 13: Patent Analysis4Free
Chapter- 14: Pipeline Analysis14Free
Chapter- 15: M&A and Venture Funding Outlook2Free
Chapter- 16: Company Profiles37Free
Chapter- 17: Appendix: Acronyms1Free

Related Reports

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Drugs and Diagnostics for Hematological Disorders: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - PHM116C

The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Melanoma Therapeutics: Global Markets

Published - Dec 2023 | Publisher - BCC Publishing | Code - PHM279A

The global market for melanoma therapeutics is estimated to increase from $7.4 billion in 2023 to reach $12.1 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.

Recent Reports

Rare Disease Diagnostics: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM227B

The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Softgel Capsules: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM244B

The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Active Pharmaceutical Ingredients: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM200C

The global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends
Sample Report